Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system (Q35660795)

9 August 2017

1 reference

title

Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system (English)

1 reference

hypertensive heart disease

9 August 2017

main subject

1 reference

Begoña López

2

0 references

author name string

Arantxa González

series ordinal

1

1 reference

9 August 2017

Javier Díez

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Medical Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

88

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

83-97

1 reference

Cardiac myocyte necrosis induced by angiotensin II

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Remodeling of the rat right and left ventricles in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Cardiac interstitium in health and disease: the fibrillar collagen network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Mechanisms of tubulointerstitial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

On the progression of chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Chronic mineralocorticoid excess and cardiovascular remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Structural basis of end-stage failure in ischemic cardiomyopathy in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Connective tissue and the heart. Functional significance and regulatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Regulation of cardiovascular collagen synthesis by mechanical load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Fibrosis and hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Clinical aspects of hypertensive myocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Chronic AT 1 Blockade Stimulates Extracellular Collagen Type I Degradation and Reverses Myocardial Fibrosis in Spontaneously Hypertensive Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Is angiotensin II a proliferative factor of cardiac fibroblasts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II, adhesion, and cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II and alpha(v)beta(3) integrin expression in rat neonatal cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II signalling pathways in cardiac fibroblasts: conventional versus novel mechanisms in mediating cardiac growth and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Identification of functional angiotensin II receptors on rat cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Effects of endothelins on collagen turnover in cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Transmural distribution of biochemical markers of total protein and collagen synthesis, myocardial contraction speed and capillary density in the rat left ventricle in angiotensin II-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Regulation and Role of Myocardial Collagen Matrix Remodeling in Hypertensive Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II induces TIMP-1 production in rat heart endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Effect of growth factors on collagen metabolism in cultured human heart fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Matrix metalloproteinases and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Structural remodeling in hypertensive heart disease and the role of hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Mineralocorticoids, hypertension, and cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Cardiac aldosterone production in genetically hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Aldosterone is produced from ventricles in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Aldosterone antagonist improves diastolic function in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarctio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(03)00125-1

10.1016/S0025-7125(03)00125-1

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference